Results 261 to 270 of about 556,334 (392)

Genetic Diversity and Selection of <i>MHC I-UAA</i> in Clariid Catfish from Thailand: Implications for Breeding and Conservation. [PDF]

Genes (Basel)
Nguyen THD, Chalermwong P, Patta C, Jaito W, Singchat W, Panthum T, Budi T, Sriphairoj K, Hatachote S, Srisapoome P, Muangmai N, Griffin DK, Antunes A, Duengkae P, Srikulnath K.   +14 more
europepmc   +1 more source

The complete sequence of the MHC class II chain RT1Dα^uof the diabetic BB rat: mRNA levels of RT1.Dα in lymphocytes

, 1987
Eugene W. Holowachuk, M.-L. Greer, Diego R. Martín   +2 more
openalex   +2 more sources

Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential. [PDF]

, 1984
Hiromichi Ishikawa, Eiro Kubota, Kayoko Saito   +2 more
openalex   +1 more source

Peptides bound to MHC [PDF]

Nature, 1992
openaire   +3 more sources

Glucocorticoid Receptor Activation Reprograms NK Cells to Drive AREG‐Mediated Immunosuppression: A Pan‐Cancer Role for AREG

Advanced Science, EarlyView.
Natural killer cells, central to anti‐tumor defense, undergo unexpected reprogramming within the tumor microenvironment. Instead of producing IFN‐γ and TNF‐α, they elevate amphiregulin, a tumor‐promoting factor. This shift is linked to glucocorticoid receptor activity and prostaglandin signaling.
Qin Wei, Guirong Liang, Rui zeng, Yuancheng Li, Anlan Hong, Hongsheng Wang, Suying Feng, Yan Wang, Yetao Wang   +8 more
wiley   +1 more source

The Avian MHC-Antigen System

The Journal of Poultry Science, 2002
Diana Wesselinova
doaj   +1 more source

Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains. [PDF]

Acta Neuropathol Commun
Najm L, Chomyk A, Cyncynatus K, Davalos D, Mahajan KR, Trapp BD.   +5 more
europepmc   +1 more source

Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. [PDF]

, 1986
L A Lampson, William F. Hickey
openalex   +1 more source

Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

Advanced Science, EarlyView.
Strategies for TME‐responsive Nanomaterials to Potentiate Cancer Immunotherapy. Abstract Immunotherapy has emerged as a transformative paradigm in oncology, yet its clinical efficacy remains constrained by the immunosuppressive tumor microenvironment and inadequate spatiotemporal control of existing modalities, resulting in suboptimal patient response ...
Qianqian Huang, Fan Tong, Jiantao Chen, Muzaffar Kayumov, Yue Lv, Yajun Shi, Bengui Ye, Huile Gao   +7 more
wiley   +1 more source

LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells. [PDF]

J Immunother Cancer
Yang Z, Meng Z, Liu S, Chen Y, Gan X, Zhang ZM, Luo X, Yan J, Chen H, Huang D, Huang L, Zeng X, Ma W, Liu J, Wang L, Huang H, Yang X, Hu M, Chen L, Du H, Leng Q, Qiu L, Wang X.   +22 more
europepmc   +1 more source